A special feature of the Counseling Psychology program is a 12-month practicum placement in our on-site Community Counseling Center. The center is a low-cost community counseling facility, which ...
Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback